Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of an Epigenetic Assay for Predicting Repeat Prostate Biopsy Outcome in African American Men

13 Apr 2018

Abstract excerpt

OBJECTIVE: To evaluate an epigenetic assay performed on tissue from negative prostate biopsies in a group of African American (AA) men undergoing repeat biopsy, and to compare accuracy for predicting repeat biopsy outcome to prior studies conducted in predominantly Caucasian populations. MATERIALS AND METHODS: The study population consisted of 211 AA men from 7 urology centers across the United States; all of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Prostate Cancer Diagnosis and Treatment
Share to Prostate Cancer Treatment and Research
Share to Urinary Bladder and Prostate Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29660369
DOI: 10.1016/j.urology.2018.04.001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of an Epigenetic Assay for Predicting Repeat Prostate Biopsy Outcome in African American MenPMID 29660369Read ↗

Performance of the Genomic Evaluators of Metastatic Prostate Cancer (GEMCaP) tumor biomarker for identifying recurrent disease in African American patients.Semantic proximity Read ↗

DNA methylation in repeat negative prostate biopsies as a marker of missed prostate cancer.Semantic proximity Read ↗

A west African ancestry-associated SNP on 8q24 predicts a positive biopsy in African American men with suspected prostate cancer following PSA screening.Semantic proximity Read ↗

DNA methylation biomarkers of prostate cancer: Confirmation of candidates and evidence urine is the most sensitive body fluid for non‐invasive detectionSemantic proximity Read ↗

Prostate Cancer Detected by Methylated Gene Markers in Histopathologically Cancer-Negative Tissues from Men with Subsequent Positive BiopsiesSemantic proximity Read ↗

epiCaPture: A Urine DNA Methylation Test for Early Detection of Aggressive Prostate CancerSemantic proximity Read ↗

High Concordance of Gene Methylation in Post-Digital Rectal Examination and Post-Biopsy Urine Samples for Prostate Cancer DetectionSemantic proximity Read ↗

Epigenetic analysis identifies factors driving racial disparity in prostate cancerSemantic proximity Read ↗

Testing for the recurrent HOXB13 G84E germline mutation in men with clinical indications for prostate biopsy.Semantic proximity Read ↗

A panel of DNA methylation markers for the detection of prostate cancer from FV and DRE urine DNASemantic proximity Read ↗

Epigenetic signature of Gleason score and prostate cancer recurrence after radical prostatectomySemantic proximity Read ↗

A Urine-Based Exosomal Gene Expression Test Stratifies Risk of High-Grade Prostate Cancer in Men with Prior Negative Prostate Biopsy Undergoing Repeat BiopsySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.